COMP <GO>
NAUT vs LAB // FORWARD P/E MULTIPLE
Nautilus Biotechnology Inc. (NASDAQ) VS. Standard BioTools Inc. (NASDAQ) • 15-METRIC TALLY: NAUT 2
— LAB 2
■ METRIC PARITY
LAST: $3.14 (-2.18%) • MKT CAP: $399.9M
forward-pe
—
LAST: $0.62 (+0.49%) • MKT CAP: $244.7M
forward-pe
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (NAUT VS. LAB)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | NAUT | LAB | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 49.90% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -28.70% | -6.30 | LAB | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -12.99% | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | — | -60.00% | — | TIE | /operating-margins <GO> |
| Net Profit Margin | — | -60.00% | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | — | -6.20% | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | 0.20 | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 3/9 | 4/9 | -1.00 | LAB | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 57.4 | 37.8 | +19.66 | NAUT | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple ACTIVE | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $399.9M | $244.7M | $155.3M | NAUT | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | NAUT REV | LAB REV | NAUT GROSS % | LAB GROSS % | NAUT FCF | LAB FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $0 | $85.3M | — | 49.9% | -$52.0M | -$82.6M |
| FY 2024 | $0 | $91.0M | — | 49.3% | -$61.3M | -$151.8M |
| FY 2023 | $0 | $106.3M | — | — | -$51.7M | -$43.3M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
NAUT // BETA —
LAB // BETA —